Key statistics
As of last trade, Heart Test Laboratories Inc (HSCS:NAQ) traded at 4.04, 71.19% above the 52 week low of 2.36 set on Sep 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.05 |
---|---|
High | 4.30 |
Low | 4.02 |
Bid | 4.05 |
Offer | 4.29 |
Previous close | 4.06 |
Average volume | 115.65k |
---|---|
Shares outstanding | 913.32k |
Free float | 818.13k |
P/E (TTM) | -- |
Market cap | 3.71m USD |
EPS (TTM) | -5.65 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 18:19 BST.
More ▼
Announcements
- HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
- HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
- HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
- Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
- HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare
- HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction
- HeartSciences Regains Compliance with Nasdaq Listing Requirements
- HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio
- HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
- HeartSciences to Present at the LD Micro Invitational XIV Conference
More ▼